Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.

NCT07213713 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Obese Patients

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS